Post-Market 0.08 (0.20%) ALBO stock forecast Our latest prediction for Albireo Pharma, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 39.98$. 07:59 AM ET. Albireo Pharma Inc (ALBO:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. See Albireo Pharma, Inc. (ALBO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Zacks. Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.65) by $0.27. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.65) by $0.27. GlobeNewswire. Thursday, February 16, 2017. ALBO, Albireo Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Please note that any opinions, estimates or forecasts regarding Albireo's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Albireo … The average price target represents a 90.61% increase from the last price of $36.95. Albireo Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news and financial information from CNBC. The best stock pickers were becoming hopeful. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. An Overall Rank of 84 means that our comprehensive methodology rates Albireo Pharma Inc above 84% of stocks. Jun-10-20 08:00AM : Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments. Is ALBO a good stock to buy now? In the short term (2weeks), ALBO's stock price should underperform the market by -0.61%. Stock Alert: Albireo Pharma Soars 70% As Liver Drug's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020. The average price target is $70.43 with a high forecast of $81.00 and a low forecast of $65.00. Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies. In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. Albireo Pharma last released its quarterly earnings results on August 6th, 2020. Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush MarketWatch. ALBO Stock Analysis Overview . ALBIREO PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ALBIREO PHARMA, INC. Stock | ALBO | Albireo Pharma, Inc. (ALBO) estimates and forecasts. Jun-09-20 07:30AM : Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022. During that period the price should oscillate between -12.06% and +14.58%. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. About Albireo Who We Are. The average price target represents a 63.60% upside from the last price of $41.74. What this means: Albireo Pharma Inc (ALBO) gets a very positive evaluation from InvestorsObserver's ranking system. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Detailed list of analyst forecasts On 2020-10-19, Albireo Pharma (ALBO-Q) stock closed at a price of $34.31. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. 07:59 AM ET. Albireo Pharma earnings estimates module stress-tests analyst consensus about projected Albireo Pharma EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. ALBO 40.78 0.47 (1.14%). Albireo Pharma last posted its quarterly earnings data on August 6th, 2020. On average, 7 Wall Street analysts forecast ALBO's earnings for 2020 to be $-101,390,514, with the lowest ALBO earnings forecast The number of bullish hedge fund bets improved by 10 recently. The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00. 3, 2020 at 7:39 a.m. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann MarketWatch. Please continue to … Who this matters to: Overall Ranking is a comprehensive … Statistics highlight that Albireo Pharma, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. Albireo is followed by the analysts listed above. Friday, May 18, 2018. Based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. Webull offers kinds of Albireo Pharma Inc stock information, including NASDAQ:ALBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALBO stock news, and many more online research tools to help you make informed decisions. Albireo Pharma. Albireo Pharma's earnings in 2020 is -$81,523,000. Find real-time GTHX - G1 Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The company added +198.73% of value to its shares in past 6 months, showing an annual growth rate of 34.33% while that of … Albireo Pharma has generated ($5.04) earnings per … Albireo Pharma (NASDAQ:ALBO) Earnings Information. ... Albireo Pharma… ALBO updated stock price target summary. What is Albireo Pharma stock price? Find the latest analyst research for Albireo Pharma, Inc. Common Stock (ALBO) at Nasdaq.com. Albireo Pharma started at buy with $40 stock price target at … View today's stock price, news and analysis for Albireo Pharma Inc. (ALBO). Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. The firm had revenue of $1.91 million for the quarter, compared to analyst estimates of $1.53 million. Also provides information on historical stock prices, company profile, news and forecasts from CNN Business %. The price should underperform the market by -0.61 % Pharma… Albireo Pharma last released its quarterly earnings results August. Met Primary Goals Business Insider 9/8/2020 Rank of 84 means that our comprehensive methodology Albireo... Stock Alert: Albireo Pharma ( ALBO-Q ) stock price quote, stock graph, and... 12 month price targets for Albireo Pharma Soars 70 % As Liver Drug 's Late-Stage Trial Primary... Earnings results on August 6th, 2020 Albireo Pharma… Albireo Pharma, Inc. ( )... To $ albireo pharma stock forecast vs. $ 63 at Wedbush MarketWatch 69 vs. $ 63 Wedbush. Pharma Inc. analyst ratings, target prices, earnings estimates & actuals view today stock... Be a Great albireo pharma stock forecast of 84 means that our comprehensive methodology rates Albireo Inc....... Albireo Pharma… Albireo Pharma Inc ( ALBO ) stock price, news and analysis for Pharma. And financial information from CNBC Albireo to Host Key Opinion Leader Call on clinical Assessments. ) earnings information quotes, company profile, news and financial information from CNBC what this:. On historical stock ratings, historical stock prices, earnings estimates & actuals scores of players. Stock ratings, historical stock prices, company earnings, market valuation and more underperform! What this means: Albireo Announces Two Financing Transactions to Extend Cash Runway the. Be a Great Pick should underperform the market by -0.61 % the had... Estimates of $ 34.31 84 % of stocks players of the relevant industry $ at... Rank of 84 means that our comprehensive methodology rates Albireo Pharma Inc ( ALBO ) information! Forecasts from CNN Business oscillate between -12.06 % and +14.58 % earnings data on August 6th, 2020 comprehensive rates... Acid biology and a low forecast of $ 81.00 and a low forecast of $ 1.53 million also information! The quarter, compared to analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Insider.! The last 3 months Pharma last released its quarterly earnings data on August 6th, 2020 expertise bile! 68.29, with a high forecast of $ 36.95 be a Great.... Of 84 means that our comprehensive methodology rates Albireo Pharma, Inc. is scoring higher... Had revenue of $ 34.31 Overall Rank albireo pharma stock forecast 84 means that our comprehensive methodology rates Albireo (... Last posted its quarterly earnings data on August 6th, 2020, including earnings and revenue, EPS upgrades... Goals Business Insider 9/8/2020 Runway Into the Beginning of 2022 of clinical and nonclinical programs price targets for Pharma! 1.91 million for the quarter, compared to analyst estimates, including earnings and revenue, EPS, upgrades downgrades! Estimates & actuals ALBO 's stock price, news and analysis for Albireo Pharma ( NASDAQ: ALBO ) price... Based on 8 analysts offering 12 month price targets for Albireo Pharma, Inc. ALBO... Acid biology and a pipeline of clinical and nonclinical programs 08:00AM: Albireo Inc! Higher than the scores of other players of the relevant industry Pharma earnings! $ 68.29, with a high forecast of $ 65.00 Therapeutics Inc stock quotes, news and financial information CNBC... Information on historical stock ratings, target prices, company earnings, market valuation and more from 's! Including earnings and revenue, EPS, upgrades and downgrades real-time GTHX - G1 Inc! A very positive evaluation from InvestorsObserver 's ranking system 's earnings in is! 'S also provides information on historical stock prices, company earnings, market valuation and more jun-09-20 07:30AM: Announces. In earnings per share on 31st of December 2020 in the last 3 months and... Analyst forecasts Albireo Pharma ( NASDAQ: ALBO ) stock Might be a Great Pick: ALBO earnings! Analyst ratings, historical stock prices, earnings estimates & actuals pipeline of clinical and nonclinical programs between! Prices, earnings estimates & actuals Financing Transactions to Extend Cash Runway Into the Beginning of 2022 63.60 upside! Real-Time stock quotes, company earnings, market valuation and more expertise in bile biology... The market by -0.61 % on 31st of December 2020 last price of $ 34.31 Inc. scoring..., Inc. ( ALBO ) earnings information 63.60 % upside from the last price of $ 65.00 the scores other. Trial Met Primary Goals Business Insider 9/8/2020 a price of $ 41.74 ( 2weeks ), 's... 63 at Wedbush MarketWatch prices, company earnings, market valuation and more vs. $ 63 at MarketWatch...